Skip to main content
. Author manuscript; available in PMC: 2019 Sep 4.
Published in final edited form as: Mol Pharm. 2018 Aug 13;15(9):3881–3891. doi: 10.1021/acs.molpharmaceut.8b00355

Figure 7. Optimized Low Molecular Weight Scavenger Receptor Inhibitor PEG-Peptides.

Figure 7.

The percent of 125I-PEG-peptide recovered from the liver at a biodistribution time of 5 min following i.v. administration of triplicate mice under dose escalation of 1–80 nmol is illustrated. The IC50 is determined from the PEG-peptide concentration resulting in 50% saturation of liver uptake, assuming a 2 ml blood volume. The IC50 values of 3–40 μM were derived from fitting the results with R2 =0.93, 0.7, 0.82 and 0.82 for panels A-D. A value of p < 0.05 was determined for each PEG-peptides 28, 29, 32, and 33 when comparing 1 and 80 nmol dose.